Neofordex (Dexamethasone)

• Neofordex, a glucocorticoid, acts on inflammatory and immune pathways to provide therapeutic benefit across several disease groups.
• Inflammatory and autoimmune disorders: reduces inflammation and suppresses aberrant immune activity.
• Allergic reactions: mitigates severe hypersensitivity responses.
• Certain cancers (as part of chemotherapy regimens): helps control tumor‑related inflammation and edema.
• Adrenal insufficiency (replacement therapy): provides necessary glucocorticoid activity when endogenous production is inadequate.

• Dexamethasone binds to intracellular glucocorticoid receptors, forming a complex that translocates to the nucleus and interacts with glucocorticoid response elements on DNA. This alters transcription of multiple genes, leading to decreased production of pro‑inflammatory cytokines, inhibition of leukocyte migration, and suppression of immune cell activation, thereby exerting potent anti‑inflammatory and immunosuppressive effects.

Neofordex may cause a range of adverse reactions, from mild to severe, depending on dose and duration of therapy.

Common Side Effects

• Increased appetite and weight gain.
• Insomnia or sleep disturbances.
• Mild gastrointestinal discomfort such as nausea.
• Fluid retention causing mild swelling.

Serious or Rare Side Effects

• Severe infections due to immunosuppression.
• Adrenal insufficiency on abrupt discontinuation.
• Hyperglycemia or worsening of diabetes.
• Psychiatric disturbances including mood swings or psychosis.
• Osteoporosis with long‑term use.

• Before initiating Neofordex, clinicians should evaluate several safety considerations.
• Assess for active infection: avoid use in uncontrolled infections.
• Monitor blood glucose: adjust antidiabetic therapy as needed.
• Use the lowest effective dose: limit duration to reduce risk of systemic effects.
• Avoid abrupt discontinuation: taper gradually to prevent adrenal crisis.
• Store at room temperature: keep in the original pack, protect from moisture and direct sunlight.

Neofordex can interact with other medicines, altering its efficacy or safety profile.

Major Interactions (Avoid)

• Potent CYP3A4 inhibitors (e.g., ketoconazole): may increase dexamethasone exposure and toxicity.
• Live vaccines: immunosuppression can reduce vaccine effectiveness and increase infection risk.

Moderate Interactions (Monitor Closely)

• NSAIDs: combined use raises risk of gastrointestinal ulceration or bleeding.
• Antidiabetic agents: dexamethasone may raise blood glucose, requiring dose adjustments.
• Anticoagulants (e.g., warfarin): may enhance anticoagulant effect, necessitating INR monitoring.